You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV Treatment Experienced

Showing 1 - 25 of 4,954
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • ABT-450/r/ABT-267, ABT-333
  • +4 more
  • (no location specified)
Jul 29, 2021

Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

Active, not recruiting
  • Hepatitis C Virus (HCV)
    • Chelyabinsk, Russian Federation
    • +9 more
    Mar 1, 2022

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Virus Infection Trial in Bani Sweif (SOF/SMV/DCV/RBV)

    Completed
    • Chronic Hepatitis C Virus Infection
    • Bani Sweif, Egypt
      Health Administration at Beni-Seuf
    May 10, 2020

    Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

    Not yet recruiting
    • Hepatitis C
    • Cirrhosis
    • (no location specified)
    Jul 20, 2022

    Hepatitis C Trial in Australia (OraQuick HCV Antibody test (OraSure Technologies, Inc), Xpert HCV Viral Load Finger-stick

    Recruiting
    • Hepatitis C
    • OraQuick HCV Antibody test (OraSure Technologies, Inc)
    • +2 more
    • Clayton South, Victoria, Australia
    • +5 more
    Aug 16, 2022

    HCV-TARGET- Hepatitis C Therapeutic Registry and Research

    Active, not recruiting
    • Hepatitis C
      • Phoenix, Arizona
      • +59 more
      Oct 5, 2022

      Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

      Completed
      Has Results
      • Hepatitis C Virus (HCV)
      • Glecaprevir/pibrentasvir adult formulation
      • Glecaprevir/pibrentasvir pediatric formulation
      • San Francisco, California
      • +37 more
      Sep 19, 2022

      Chronic HCV Infection Trial in China, Korea, Republic of, Taiwan (LDV/SOF)

      Completed
      Has Results
      • Chronic HCV Infection
      • Beijing, China
      • +44 more
      Feb 18, 2020

      Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

      Recruiting
      • Hepatitis C Infection
      • HIV Infection
      • Glecaprevir/Pibrentasvir (G/P)
      • Ribavirin (RBV)
      • San Diego, California
      • +15 more
      Dec 19, 2022

      Hepatitis C Trial in San Diego (Simplified HCV care within a mobile medical unit)

      Enrolling by invitation
      • Hepatitis C
      • Simplified HCV care within a mobile medical unit
      • San Diego, California
        Family Health Centers of San Diego
      Mar 14, 2022

      End Stage Renal Disease, Chronic Hepatitis c Trial in Boston (Glecaprevir / Pibrentasvir Oral Tablet [Mavyret])

      Withdrawn
      • End Stage Renal Disease
      • Chronic Hepatitis c
      • Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
      • Boston, Massachusetts
        Massachusetts General Hospital
      Mar 4, 2022

      HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))

      Completed
      Has Results
      • HIV Infections
      • Hepatitis C
      • Pegylated-Interferon Alfa 2b (PEG-IFN)
      • +2 more
      • Birmingham, Alabama
      • +42 more
      Nov 2, 2021

      Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)

      Completed
      Has Results
      • Chronic Hepatitis C Virus
      • Hepatitis C Virus
      • (no location specified)
      Jul 14, 2021

      HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

      Completed
      Has Results
      • HCV
      • +2 more
      • (no location specified)
      Jul 28, 2021

      Against HCV Based on Direct-acting Antivirals in Real-life

      Completed
      • Chronic Hepatitis C Infection
      • Seville, Andalusia, Spain
        Valme University Hospital
      Jun 22, 2022

      HIV, Hepatitis C Trial in Puerto Rico, United States (Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT), Dasabuvir (DSV), Ribavirin

      Terminated
      Has Results
      • HIV Infections
      • Hepatitis C
      • Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
      • +2 more
      • Birmingham, Alabama
      • +15 more
      Nov 2, 2021

      Hepatitis C Trial in Darlinghurst, Sydney, Adelaide (Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg))

      Recruiting
      • Hepatitis C
      • Sofosbuvir 400mg [Sovaldi]
      • Glecaprevir/pibrentasvir (300mg/120mg)
      • Darlinghurst, New South Wales, Australia
      • +2 more
      Mar 28, 2022

      HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

      Completed
      Has Results
      • HIV Infection
      • Hepatitis C Infection
      • Nitazoxanide (NTZ)
      • +2 more
      • Birmingham, Alabama
      • +17 more
      Nov 2, 2021

      Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

      Completed
      Has Results
      • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
      • Phoenix, Arizona
      • +47 more
      Jun 27, 2022

      Hepatitis C, Medication Adherence Trial in Bronx (AiCure, AiCure with gamification)

      Completed
      Has Results
      • Hepatitis C
      • Medication Adherence
      • AiCure
      • AiCure with gamification
      • Bronx, New York
        Albert Einstein College of Medicine Division of Substance Abuse
      Aug 19, 2021

      HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)

      Withdrawn
      • HIV Infections
      • +2 more
      • Adefovir dipivoxil
      • +3 more
      • (no location specified)
      Oct 28, 2021

      Hepatitis C Virus Infection Trial in Korea, Republic of (SOF/VEL, SOF/VEL/VOX)

      Completed
      Has Results
      • Hepatitis C Virus Infection
      • Seongnam-si, Gyeonggi-D, Korea, Republic of
      • +21 more
      Sep 29, 2021